Trigeminal neuropathy: Two case reports of gasserian ganglion stimulation

Abstract This report describes the successful treatment of two patients with trigeminal neuropathy by using gasserian ganglion stimulation. Case reports: The first case report deals with a 53‐year‐old woman suffering from right‐sided facial pain after a gamma knife lesion for schwannoma of the right...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yannick Logghe, Iris Smet, Ali Jerjir, Peter Verelst, Marieke Devos, Jean‐Pierre Van Buyten
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/e9812a64b31e4006b30d9ca020122382
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e9812a64b31e4006b30d9ca020122382
record_format dspace
spelling oai:doaj.org-article:e9812a64b31e4006b30d9ca0201223822021-11-25T06:06:36ZTrigeminal neuropathy: Two case reports of gasserian ganglion stimulation2162-327910.1002/brb3.2379https://doaj.org/article/e9812a64b31e4006b30d9ca0201223822021-11-01T00:00:00Zhttps://doi.org/10.1002/brb3.2379https://doaj.org/toc/2162-3279Abstract This report describes the successful treatment of two patients with trigeminal neuropathy by using gasserian ganglion stimulation. Case reports: The first case report deals with a 53‐year‐old woman suffering from right‐sided facial pain after a gamma knife lesion for schwannoma of the right inner ear. For 9 years, several interventions with the aim of relieving the pain were unsuccessful; in fact, they had aggravated the symptoms. A trial with a neurostimulator at the level of the Gasser ganglion had an immediately positive effect on her score for facial pain, which decreased from 7.3 to 0 on a visual analog scale, assessed during a period of 2 months. Additionally, the patient had weaned off all her medication by the end of the period. The second case report describes a 64‐year‐old man suffering from trigeminal neuropathy, which mainly manifested itself as an itch. For a period of 15 years, neither medication nor several interventions were effective. A trial with an electrode at the level of the Gasser ganglion reduced his pain score from 7.0 to 1.5 on a visual analog scale, assessed during a period of three months. His medication could be limited to pregabalin 150 mg bidaily. In contrast, prior to the implantation, his oral medication consisted of pregabalin 75 mg up to five times a day. Conclusion: These case reports show that stimulation of the gasserian ganglion is a successful, minimally invasive, and non‐destructive treatment in refractory trigeminal neuropathy and should be considered earlier in the treatment algorithm of trigeminal neuropathy.Yannick LoggheIris SmetAli JerjirPeter VerelstMarieke DevosJean‐Pierre Van BuytenWileyarticlegasserian ganglionpainneuromodulationpaintrigeminal neuropathypainNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENBrain and Behavior, Vol 11, Iss 11, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic gasserian ganglionpain
neuromodulation
pain
trigeminal neuropathypain
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle gasserian ganglionpain
neuromodulation
pain
trigeminal neuropathypain
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Yannick Logghe
Iris Smet
Ali Jerjir
Peter Verelst
Marieke Devos
Jean‐Pierre Van Buyten
Trigeminal neuropathy: Two case reports of gasserian ganglion stimulation
description Abstract This report describes the successful treatment of two patients with trigeminal neuropathy by using gasserian ganglion stimulation. Case reports: The first case report deals with a 53‐year‐old woman suffering from right‐sided facial pain after a gamma knife lesion for schwannoma of the right inner ear. For 9 years, several interventions with the aim of relieving the pain were unsuccessful; in fact, they had aggravated the symptoms. A trial with a neurostimulator at the level of the Gasser ganglion had an immediately positive effect on her score for facial pain, which decreased from 7.3 to 0 on a visual analog scale, assessed during a period of 2 months. Additionally, the patient had weaned off all her medication by the end of the period. The second case report describes a 64‐year‐old man suffering from trigeminal neuropathy, which mainly manifested itself as an itch. For a period of 15 years, neither medication nor several interventions were effective. A trial with an electrode at the level of the Gasser ganglion reduced his pain score from 7.0 to 1.5 on a visual analog scale, assessed during a period of three months. His medication could be limited to pregabalin 150 mg bidaily. In contrast, prior to the implantation, his oral medication consisted of pregabalin 75 mg up to five times a day. Conclusion: These case reports show that stimulation of the gasserian ganglion is a successful, minimally invasive, and non‐destructive treatment in refractory trigeminal neuropathy and should be considered earlier in the treatment algorithm of trigeminal neuropathy.
format article
author Yannick Logghe
Iris Smet
Ali Jerjir
Peter Verelst
Marieke Devos
Jean‐Pierre Van Buyten
author_facet Yannick Logghe
Iris Smet
Ali Jerjir
Peter Verelst
Marieke Devos
Jean‐Pierre Van Buyten
author_sort Yannick Logghe
title Trigeminal neuropathy: Two case reports of gasserian ganglion stimulation
title_short Trigeminal neuropathy: Two case reports of gasserian ganglion stimulation
title_full Trigeminal neuropathy: Two case reports of gasserian ganglion stimulation
title_fullStr Trigeminal neuropathy: Two case reports of gasserian ganglion stimulation
title_full_unstemmed Trigeminal neuropathy: Two case reports of gasserian ganglion stimulation
title_sort trigeminal neuropathy: two case reports of gasserian ganglion stimulation
publisher Wiley
publishDate 2021
url https://doaj.org/article/e9812a64b31e4006b30d9ca020122382
work_keys_str_mv AT yannicklogghe trigeminalneuropathytwocasereportsofgasserianganglionstimulation
AT irissmet trigeminalneuropathytwocasereportsofgasserianganglionstimulation
AT alijerjir trigeminalneuropathytwocasereportsofgasserianganglionstimulation
AT peterverelst trigeminalneuropathytwocasereportsofgasserianganglionstimulation
AT mariekedevos trigeminalneuropathytwocasereportsofgasserianganglionstimulation
AT jeanpierrevanbuyten trigeminalneuropathytwocasereportsofgasserianganglionstimulation
_version_ 1718414196566130688